Jiangjun Cao
Overview
Explore the profile of Jiangjun Cao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peng P, Cao J, Cheng W, Ming H, He B, Duan X, et al.
Acta Biomater
. 2025 Jan;
194:467-482.
PMID: 39832699
In situ vaccine (ISV) can activate the anti-tumor immune system by inducing immunogenic cell death (ICD) at the tumor site. However, the development of tumor ISV still faces challenges due...
2.
Cao J, Zhao E, Zhu Q, Ji J, Wei Z, Xu B, et al.
Cells
. 2024 Sep;
13(18).
PMID: 39329782
In the Correspondence information of the original publication [...].
3.
Cao J, Zhang Z, Zhou L, Luo M, Li L, Li B, et al.
MedComm (2020)
. 2023 Dec;
4(6):e427.
PMID: 38045829
Emerging evidence indicates that cancer cells can mimic characteristics of embryonic development, promoting their development and progression. Cancer cells share features with embryonic development, characterized by robust proliferation and differentiation...
4.
He K, Wang Z, Luo M, Li B, Ding N, Li L, et al.
J Transl Med
. 2023 Sep;
21(1):612.
PMID: 37689664
Distant metastasis remains a leading cause of mortality among patients with colorectal cancer (CRC). Organotropism, referring to the propensity of metastasis to target specific organs, is a well-documented phenomenon in...
5.
Zhang G, Zhu Q, Fu G, Hou J, Hu X, Cao J, et al.
Br J Cancer
. 2023 Jun;
129(3):563-564.
PMID: 37336962
No abstract available.
6.
Tian H, Cao J, Li B, Nice E, Mao H, Zhang Y, et al.
Bone Res
. 2023 Feb;
11(1):11.
PMID: 36849442
Osteosarcoma, with poor survival after metastasis, is considered the most common primary bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival rate has only shown limited improvement,...
7.
He B, Zhang Z, Huang Z, Duan X, Wang Y, Cao J, et al.
Biochem Pharmacol
. 2023 Feb;
209:115444.
PMID: 36736962
The past few decades have witnessed significant progress in the discovery of hydrogen sulfide (HS) as a ubiquitous gaseous signaling molecule in mammalian physiology, akin to nitric oxide and carbon...
8.
Li L, Jin P, Guan Y, Luo M, Wang Y, He B, et al.
Pharmaceuticals (Basel)
. 2022 Dec;
15(12).
PMID: 36558995
Polyphenol, one of the major components that exert the therapeutic effect of Chinese herbal medicine (CHM), comprises several categories, including flavonoids, phenolic acids, lignans and stilbenes, and has long been...
9.
Zhang G, Zhu Q, Fu G, Hou J, Hu X, Cao J, et al.
Br J Cancer
. 2019 Nov;
121(12):1069-1078.
PMID: 31740732
Background: Thyroid hormone receptor interactor 13 (TRIP13) is an AAA + ATPase that plays an important role in the mitotic checkpoint. TRIP13 is highly expressed in various human tumours and...
10.
Cao J, Zhao E, Zhu Q, Ji J, Wei Z, Xu B, et al.
Cells
. 2019 Jul;
8(8).
PMID: 31349699
Tubeimoside-1 (TBMS1) is one of the extracts of rhizoma bolbostemmae, which has remarkable anti-cancer function in the treatment of esophagus and gastric cancer in traditional Chinese medicine. However the mechanisms...